Most Expensive
request_quoteIndulge in the exquisite details and unparalleled quality of the most expensive products and assets that define luxury living.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardPE Ratio | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CGNTCognyte Software Ltd. | $10.71 | $0.08 | arrow_drop_up0.74% | $704.45M | 122.07K | 10.66 | - | Neutralremove | - | 44.40% | |||||
HCVI HCVIHennessy Capital Investment Corp. VI | $11.67 | $0.82 | arrow_drop_up7.55% | $170.85M | 19.21K | 11.95 | - | Neutralremove | - | 10.93% | |||||
BMN BMNBlackRock 2037 Municipal Target Term Trust | $24.11 | $0.11 | arrow_drop_up0.47% | $147.35M | 4.44K | 24.15 | - | Neutralremove | - | -2.91% | |||||
RWAY RWAYZRunway Growth Finance Corp. - 8.00% Notes due 2027 | $25.11 | -$0.03 | arrow_drop_down0.11% | $7.32B | 106.00 | 25.11 | - | Neutralremove | - | -0.19% | |||||
WELIntegrated Wellness Acquisition | $11.91 | -$0.04 | arrow_drop_down0.33% | $84.56M | 1.20K | 12.01 | - | Neutralremove | - | 3.65% | |||||
AVDAmerican Vanguard | $4.20 | -$0.05 | arrow_drop_down1.17% | $118.03M | 102.37K | 4.22 | - | Neutralremove | 2.33% | -54.09% | |||||
PRLDPrelude Therapeutics Incorporated | $0.87 | -$0.03 | arrow_drop_down3.76% | $52.90M | 60.10K | 0.87 | - | Neutralremove | - | -78.71% | |||||
AEAdams Resources & Energy | $37.98 | $0.00 | 0.00% | $97.77M | 6.98K | 38.27 | - | Neutralremove | 2.53% | 34.68% | |||||
ASXCAsensus Surgical | $0.35 | $0.00 | arrow_drop_up0.60% | $94.92M | 0.00 | 4.03M | - | Neutralremove | - | 43.20% | |||||
CRDLCardiol Therapeutics | $1.09 | $0.03 | arrow_drop_up2.80% | $94.22M | 192.27K | 1.09 | - | Neutralremove | - | -49.77% | |||||
ANIXAnixa Biosciences | $2.48 | -$0.13 | arrow_drop_down5.00% | $81.13M | 34.46K | 2.50 | - | Neutralremove | - | -4.61% | |||||
SLSSELLAS Life Sciences Group | $1.89 | $0.14 | arrow_drop_up7.95% | $159.64M | 2.61M | 1.86 | - | Neutralremove | - | 32.51% | |||||
AKYAAkoya Biosciences | $1.26 | -$0.04 | arrow_drop_down3.07% | $49.87M | 317.39K | 1.26 | - | Neutralremove | - | -44.63% | |||||
IVVDInvivyd | $0.72 | -$0.03 | arrow_drop_down4.35% | $84.45M | 5.16M | 0.79 | - | Neutralremove | - | -66.29% | |||||
CLOVClover Health Investments, | $3.19 | -$0.07 | arrow_drop_down2.28% | $1.73B | 5.55M | 3.19 | - | Neutralremove | - | 213.23% | |||||
VRAVera Bradley | $2.03 | -$0.10 | arrow_drop_down4.90% | $58.90M | 67.38K | 2.02 | - | Neutralremove | - | -73.67% | |||||
AKAa.k.a. Brands Holding | $12.79 | -$0.30 | arrow_drop_down2.36% | $161.04M | 10.77K | 13.00 | - | Neutralremove | - | -25.55% | |||||
CYHCommunity Health Systems | $3.69 | -$0.00 | arrow_drop_down0.13% | $601.91M | 1.20M | 3.73 | - | Neutralremove | - | 0.68% | |||||
TNYATenaya Therapeutics | $0.43 | -$0.00 | arrow_drop_down0.29% | $71.12M | 1.57M | 0.42 | - | Neutralremove | - | -90.20% | |||||
ALKTAlkami Technology | $29.16 | $0.08 | arrow_drop_up0.27% | $3.14B | 345.80K | 29.13 | - | Neutralremove | - | 4.38% |
Showing 4541-4560 of 4978
Results per page:
About Most Expensive
Discover the world of the most expensive stocks, where share prices reach extraordinary heights. These stocks command premium valuations, reflecting investor confidence and perceived value in the companies.
Investors seeking prestigious opportunities may find these high-priced stocks alluring, as they often represent established and successful companies with strong market positions.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools